Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells

Immunology and Cell Biology

Volumn 94, Issue 7, 2016, Pages 673-679

  Brown, Gabriella K ^a,b   Tovar, Cesar ^a   Cooray, Anne A ^a,c   Kreiss, Alexandre ^a   Darby, Jocelyn ^a   Murphy, James M ^d,e   Corcoran, Lynn M ^d,e   Bettiol, Silvana S ^f   Lyons, A Bruce ^f   Woods, Gregory M ^a,f  

^a UNIVERSITY OF TASMANIA   (Australia)

^b DEPARTMENT OF HEALTH   (Australia)

^c Bioline (Aust) Pty Ltd   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CONCANAVALIN A; INTERLEUKIN 2; POLYINOSINIC POLYCYTIDYLIC ACID; MITOGENIC AGENT; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CANCER CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; FACE TUMOR; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MARSUPIAL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TARGET CELL; TASMANIAN DEVIL; TUMOR CELL; AGONISTS; ANIMAL; ANTIBODY PRODUCTION; CELL DEATH; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHARMACOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIBODY FORMATION; CELL DEATH; CELL LINE, TUMOR; CONCANAVALIN A; CULTURE MEDIA, CONDITIONED; CYTOTOXICITY, IMMUNOLOGIC; FACIAL NEOPLASMS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MARSUPIALIA; MITOGENS; POLY I-C; TOLL-LIKE RECEPTOR 3;

EID: 84969961824     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.38     Document Type: Article

References (36)

1. Pearse AM, Swift K. Allograft theory: transmission of devil facial-Tumour disease. Nature 2006; 439: 549
2. Siddle HV Kreiss A Eldridge MD Noonan E Clarke CJ Pyecroft S et al. Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial Proc Natl Acad A 2007 104 16221-16226
3. Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, Rebbeck CA, et al. The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 2010; 327: 84-87
4. Hamede R, McCallum H, Jones ME. Seasonal, demographic and density-related patterns of contact between Tasmanian devils (Sarcophilus harrisii): implications for transmission of devil facial tumour disease. Austral Ecol 2008; 33: 614-622
5. Hawkins CE, Baars C, Hesterman H, Hocking GJ, Jones ME, Lazenby B, et al. Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii. Biol Conserv 2006; 131: 307-324
6. Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, et al. A second transmissible cancer in Tasmanian devils. Proc Natl Acad Sci USA 2016; 113: 374-378
7. Deakin JE, Belov K, Curach NC, Green P, Cooper DW. High levels of variability in immune response using antigens from two reproductive proteins in brushtail possums. Wildlife Res 2005; 32: 1-6
8. Croix DA, Samples NK, Vandeberg JL, Stone WH. Immune response of a marsupial (Monodelphis domestica) to sheep red blood cells. Dev Comp Immunol 1989; 13: 73-78
9. Young LJ, Deane EM. Culture and stimulation of tammar wallaby lymphocytes. Vet Res Commun 2007; 31: 685-701
10. Woods GM, Howson LJ, Brown GK, Tovar C, Kreiss A, Corcoran LM, et al. Immunology of a transmissible cancer spreading among Tasmanian devils. J Immunol 2015; 195: 23-29
11. Loh R Bergfeld J Hayes D O'Hara A. Pyecroft S. Raidal S. et al. The pathology of devil facial tumor disease (DFTD) in Tasmanian devils (Sarcophilus harrisii). Vet Path 2006 43 890-895
12. Pyecroft SB, Pearse AM, Loh R, Swift K, Belov K, Fox N, et al. Towards a case definition for devil facial tumour disease: what is it? Ecohealth 2007; 4: 346-351
13. Woods GM, Kreiss A, Belov K, Siddle HV, Obendorf DL, Muller HK. The immune response of the Tasmanian devil (Sarcophilus harrisii) and devil facial tumour disease. Ecohealth 2007; 4: 338-345
14. Hamede R, Lachish S, Belov K, Woods G, Kreiss A, Pearse AM, et al. Reduced effect of Tasmanian devil facial tumor disease at the disease front. Conserv Biol 2011; 26: 124-134
15. Brown GK, Kreiss A, Lyons AB, Woods GM. Natural killer cell mediated cytotoxic responses in the Tasmanian devil. PLoS ONE 2011; 6: e24475
16. Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Vaccine 2015; 33: 3016-3025
17. Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng YY, Belov K, et al. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc Natl Acad Sci USA 2013; 110: 5103-5108
18. Palacios R. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J Immunol 1982; 128: 337-342
19. Gillis S, Smith KA, Watson J. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol 1980; 124: 1954-1962
20. Fidler IJ, Darnell JH, Budmen MB. Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A. Cancer Res 1976; 36: 3608-3615
21. Kreiss A, Fox N, Bergfeld J, Quinn SJ, Pyecroft S, Woods GM. Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii). Dev Comp Immunol 2008; 32: 544-553
22. Lion E, Anguille S, Berneman ZN, Smits EL, Van Tendeloo VF. Poly(I: C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC. PLoS ONE 2011; 6: e20952
23. Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009; 206: 1589-1602
24. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395-1403
25. Lee S, Margolin KCytokines in cancer immunotherapy. Cancers (Basel) 2011; 3: 3856-3893
26. Patchett AL, Latham R, Brettingham-Moore KH, Tovar C, Lyons AB, Woods GM. Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil. Dev Comp Immunol 2015; 53: 123-133
27. Cohen D. The biological behaviour of the transmissible venereal tumour in immunosuppressed dogs. Eur J Cancer 1973; 9: 253-258
28. Metzger MJ, Reinisch C, Sherry J, Goff SP. Horizontal transmission of clonal cancer cells causes leukemia in soft-shell clams. Cell 2015; 161: 255-263
29. Loh R, Hayes D, Mahjoor A, O'Hara A, Pyecroft S, Raidal S. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian devil (Sarcophilus harrisii). Vet Path 2006; 43: 896-903
30. McCallum H, Tompkins DM, Jones M, Lachish S, Marvanek S, Lazenby B, et al. Distribution and impacts of Tasmanian devil facial tumor disease. Ecohealth 2007; 4: 318-325
31. DPIPWE. Save the Tasmanian Devil Program. Hobart 2015 [updated 18 September 2015; cited 29 December 2015]; Available from http: //www.tassiedevil.com.au.
32. Larsson EL, Gullberg M, Coutinho A. Heterogeneity of cells and factors participating in the concanavalin A-dependent activation of T lymphocytes with cytotoxic potential. Immunobiology 1982 161: 5-20
33. Pinfold TL, Brown GK, Bettiol SS, Woods GM. Mouse model of devil facial tumour disease establishes that an effective immune response can be generated against the cancer cells. Front Immunol 2014; 5: 251
34. Pearse AM, Swift K, Hodson P, Hua B, McCallum H, Pyecroft S, et al. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population. Cancer Genet 2012; 205: 101-112
35. Babon JJ, Murphy JM. In vitro JAK kinase activity and inhibition assays. Methods Mol Biol 2013; 967: 39-55
36. Howson LJ, Morris KM, Kobayashi T, Tovar C, Kreiss A, Papenfuss AT, et al. Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors. Anat Rec (Hoboken) 2014; 297: 925-938